Project Grant R01CA287374
Award Date
9/20/24
Completion Date
8/31/29
Dollars Obligated
$398K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This $227,941 Project Grant award from the National Cancer Institute's Cancer Cause and Prevention Research program (CFDA 93.393) supports the development and piloting of the "Cancer Care Companion," an electronic health record (EHR) tool to improve communication and self-management for families of children with cancer. The award recipient, The Washington University, will engage parents and pediatric oncology clinicians to co-develop the tool, which will adapt the existing Epic MyChart...
The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded a $662,761 Cooperative Agreement to the Dartmouth-Hitchcock Clinic to develop and test a video intervention that helps parents of children with cancer discuss goals of care and make treatment decisions that align with their values. The award period runs from September 2024 to August 2026. The project aims to build the infrastructure and conduct a large randomized trial of the...
This Project Grant award for $627,939 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund a collaborative effort to develop and validate a cost-effective, scalable diagnostic solution for characterizing pediatric cancers in low- and middle-income countries (LMIC) using nanopore sequencing technology. The primary awardee, the University of North Carolina at Chapel Hill, will work with partners at St. Jude Children's Research...
This Project Grant award of $661,845, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), will support a multi-year research project titled "Unpacking Structural Racism in Quality of End-of-Life Care for Children with Cancer." The primary awardee is the University of Alabama at Birmingham, which will collaborate with sub-awardees The University of Texas Southwestern Medical Center and Dana-Farber Cancer Institute to...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) provides $185,693 to the Research Institute at Nationwide Children's Hospital to fund a digital health parent coaching intervention to improve neurodevelopmental outcomes for young childhood cancer survivors in underserved communities. The 5-year project aims to develop and evaluate a technology-enabled program that supports parents of young childhood cancer survivors, who are at high risk of...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) seeks to understand how different forms of integration among oncology care organizations impact the quality and equity of cancer care delivery. The $2,282,687 award to Harvard Medical School, with several sub-awards to partner institutions like Dartmouth-Hitchcock Clinic, Stanford University, and Vanderbilt University Medical Center, will fund a comprehensive research...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $1,237,513 to The Washington University to develop a novel combination molecular radiotherapy approach for treating relapsed and refractory neuroblastoma, the most common extracranial solid cancer in children. The research aims to evaluate the efficacy and biological effects of two high linear energy transfer radiopharmaceuticals, 77Br-MBBG targeting the norepinephrine transporter and...
This federal Project Grant award of $161,000.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a pilot study by the University of Connecticut (UConn) to explore communication about sexuality and intimacy among individuals with metastatic breast cancer (MBC) and their partners. The key objectives of the study are to: 1) identify themes in MBC patients' communication about sexuality and intimacy, 2) determine if specific...
This Project Grant award, in the amount of $269,942, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award aims to develop and pilot test a community health worker (CHW) intervention to improve lung cancer screening (LCS) uptake and address disparities in LCS among Black and Hispanic communities served by community health centers. The key products and services to be delivered include: 1) Jointly...